What is the catalog number for HCN1 Rabbit Polyclonal Antibody?

The catalog number for HCN1 Rabbit Polyclonal Antibody is orb215964.

What sizes are available for HCN1 Rabbit Polyclonal Antibody?

HCN1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is HCN1 Rabbit Polyclonal Antibody in stock?

HCN1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

HCN1 Rabbit Polyclonal Antibody

Anti-HCN1 Antibody. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1; Brain cyclic nucleotide-gated channel 1; BCNG-1; HCN1; BCNG1

UniProt

O60741

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human HCN1 recombinant protein (Position: E618-L890) . Human HCN1 shares 82% amino acid (aa) sequence identity with both mouse and rat HCN1.

Target

Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cardiovascular Research, Cell Biology, Neuroscience, Pharmacology & Drug Discovery

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat

Form

Lyophilized

Molecular Weight

120 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.